Kudryavtsev, I.; Matyushenko, V.; Stepanova, E.; Vasilyev, K.; Rudenko, L.; Isakova-Sivak, I.
In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19. Vaccines 2022, 10, 1544.
https://doi.org/10.3390/vaccines10091544
AMA Style
Kudryavtsev I, Matyushenko V, Stepanova E, Vasilyev K, Rudenko L, Isakova-Sivak I.
In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19. Vaccines. 2022; 10(9):1544.
https://doi.org/10.3390/vaccines10091544
Chicago/Turabian Style
Kudryavtsev, Igor, Victoria Matyushenko, Ekaterina Stepanova, Kirill Vasilyev, Larisa Rudenko, and Irina Isakova-Sivak.
2022. "In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19" Vaccines 10, no. 9: 1544.
https://doi.org/10.3390/vaccines10091544
APA Style
Kudryavtsev, I., Matyushenko, V., Stepanova, E., Vasilyev, K., Rudenko, L., & Isakova-Sivak, I.
(2022). In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19. Vaccines, 10(9), 1544.
https://doi.org/10.3390/vaccines10091544